The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Dhillon Punit since 2011.
This trader's CIK number is 1425052.
At the time of last reporting, Dhillon Punit was the Chief Executive Officer of Skye Bioscience, Inc.. (stock ticker symbol SKYE).
Also see all insider trading activities at Skye Bioscience, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2018 | ONCS | 3,000 | $2,640 | 220,440 | $304,757 | 475,000 | $0 |
| 2017 | ONCS | 6,000 | $5,610 | 0 | $0 | 0 | $0 |
| 2016 | ONCS | 3,000 | $4,320 | 0 | $0 | 0 | $0 |
| 2015 | ONCS | 12,500 | $59,152 | 0 | $0 | 0 | $0 |
| 2014 | ONCS | 50,000 | $40,000 | 0 | $0 | 0 | $0 |
| 2011 | ONCS | 4,394,000 | $0 | 0 | $0 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2024 | SKYE | 0 | $0 | 82,910 | $413,924 | 0 | $0 |
| 2023 | SKYE | 881,000 | $16,739 | 0 | $0 | 0 | $0 |
| 2020 | SKYE | 1,000,000 | $100,000,000,000 | 0 | $0 | 0 | $0 |
2. Skye Bioscience, Inc. (SKYE)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2018-06-27 | ONCS | Sale | 17,480 | 1.37 | 24,017 |
| 2018-06-15 | ONCS | Option Ex | 475,000 | .00 | 0 |
| 2018-06-26 | ONCS | Sale | 23,820 | 1.40 | 33,300 |
| 2018-06-25 | ONCS | Sale | 1,021 | 1.41 | 1,434 |
| 2018-06-22 | ONCS | Sale | 14,976 | 1.42 | 21,235 |
| 2018-06-19 | ONCS | Sale | 9,310 | 1.36 | 12,698 |
| 2018-06-21 | ONCS | Sale | 11,035 | 1.40 | 15,460 |
| 2018-06-28 | ONCS | Sale | 7,882 | 1.40 | 11,042 |
| 2018-06-29 | ONCS | Sale | 5,401 | 1.38 | 7,453 |
| 2018-07-05 | ONCS | Sale | 45,785 | 1.31 | 60,069 |
| 2018-06-20 | ONCS | Sale | 55,585 | 1.42 | 79,041 |
| 2018-06-18 | ONCS | Sale | 28,145 | 1.39 | 39,008 |
| 2018-02-06 | ONCS | Buy | 3,000 | .88 | 2,640 |
| 2017-07-31 | ONCS | Buy | 3,000 | .88 | 2,640 |
| 2017-01-31 | ONCS | Buy | 3,000 | .99 | 2,970 |
| 2016-07-31 | ONCS | Buy | 3,000 | 1.44 | 4,320 |
| 2015-10-16 | ONCS | Buy | 10,000 | 4.23 | 42,310 |
| 2015-06-10 | ONCS | Buy | 2,500 | 6.74 | 16,842 |
| 2014-03-19 | ONCS | Buy | 50,000 | .80 | 40,000 |
| 2011-03-01 | ONCS.D | Buy | 4,394,000 | .00 | 0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-11-15 | SKYE | Sale | 364 | 5.55 | 2,020 |
| 2024-11-18 | SKYE | Sale | 82,546 | 4.99 | 411,904 |
| 2023-08-29 | SKYE | Buy | 881,000 | .02 | 16,739 |
| 2020-08-01 | EMBI | Buy | 1,000,000 | 100,000.00 | 100,000,000,000 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Dhillon Punit (Chief Executive Officer of Skye Bioscience, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.